Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.35%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.46. In 2024 the company made an earnings per share (EPS) of โ‚น104.70 a decrease over its 2023 EPS that were of โ‚น318.79.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-133.11%
2024โ‚น104.70-67.16%
2023โ‚น318.79-199.64%
2022-โ‚น319.9399.03%
2021-โ‚น160.75-68.98%
2020-โ‚น518.23-298.06%
2019โ‚น261.66-554.64%
2018-โ‚น57.55-77.18%
2017-โ‚น252.23-326.21%
2016โ‚น111.50-134.19%
2015-โ‚น326.11-371.34%
2014โ‚น120.19-445.98%
2013-โ‚น34.7432.88%
2012-โ‚น26.14-82.07%
2011-โ‚น145.83-817.9%
2010โ‚น20.3112.73%
2009โ‚น18.02-120.79%
2008-โ‚น86.66-37.67%
2007-โ‚น139.0439.64%
2006-โ‚น99.5728.17%
2005-โ‚น77.696.25%
2004-โ‚น73.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
โ‚น272.65-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น937.84-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น332.91-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น121.45-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น132.06 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น723.82-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.60-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น323.05-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น682.20-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA